Bio-Rad's Q1 Sales Spike 13 Percent

Increased sales for its Life Sciences and Clinical Diagnostics businesses, as well as from the acquired Biotest business, pushed Bio-Rad's revenues up 13 percent for the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories